Broad Coverage For Lap-Band Helps Grow Allergan’s Obesity Sales
This article was originally published in The Gray Sheet
Executive Summary
CMS' decision to cover Allergan's Lap-Band laparoscopic adjustable gastric band for Medicare beneficiaries last February helped spark a 33% revenue jump for Allergan's obesity intervention business in 2006
You may also be interested in...
Lap-Band Gains Panel Support For Use In Less Obese, Less Sick Patients
An FDA panel has cleared the path for the agency to approve an expanded indication for Allergan's Lap-Band surgical obesity treatment to include at least 27 million additional people.
Lap-Band Gains Panel Support For Use In Less Obese, Less Sick Patients
An FDA panel has cleared the path for the agency to approve an expanded indication for Allergan's Lap-Band surgical obesity treatment to include at least 27 million additional people.
Next-gen Lap-Band
Allergan's Lap-Band AP adjustable gastric band for use in weight-loss surgery in severely obese adults will launch in the United States July 2. The device, which wraps around and constricts the stomach, improves upon the 2001-approved Lap-Band, which generated nearly $131 million in sales last year, by distributing pressure evenly throughout its 360-degree inflation area, the firm says (1"The Gray Sheet" March 19, 2007, p. 14)...